22 related articles for article (PubMed ID: 2282562)
1. Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study.
Mahmoud HA; Alsanory AAAA; Mostafa HG; Hassan ER
Nucl Med Commun; 2024 Jun; 45(6):499-509. PubMed ID: 38586956
[TBL] [Abstract][Full Text] [Related]
2. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
Kanokwongnuwat W; Penpong N
BMC Endocr Disord; 2024 Apr; 24(1):54. PubMed ID: 38664774
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital.
S SY; Padma S; Sundaram PS
Ann Nucl Med; 2024 Mar; 38(3):231-237. PubMed ID: 38277114
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study with long term follow-up of Graves' disease patients treated with low activities of 131Iodine.
Neumann R; Thomann R; Goerres GW
Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):116-125. PubMed ID: 36287041
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of compensated low-dose 131I therapy for Graves' disease.
N Engl J Med; 1984 Dec; 311(25):1635-7. PubMed ID: 6548797
[No Abstract] [Full Text] [Related]
6. A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism.
Doi SA; Loutfi I; Al-Shoumer KA
BMC Nucl Med; 2001; 1(1):1. PubMed ID: 11570980
[TBL] [Abstract][Full Text] [Related]
7. [Radioactive iodine (I-131) therapy].
Kusakabe K; Maki M
Nihon Rinsho; 1999 Aug; 57(8):1855-8. PubMed ID: 10483265
[TBL] [Abstract][Full Text] [Related]
8. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
9. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
[TBL] [Abstract][Full Text] [Related]
10. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.
Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K
Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550
[TBL] [Abstract][Full Text] [Related]
11. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
[TBL] [Abstract][Full Text] [Related]
12. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
13. Outcome following radioactive iodine therapy in Graves' disease.
Chen JY; Huang HS; Huang MJ; Lin JD; Juang JH; Huang BY; Wang PW; Liu RT
Changgeng Yi Xue Za Zhi; 1990 Dec; 13(4):258-67. PubMed ID: 2282562
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
